DK0497658T3 - Anvendelse af (omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)-1H-azolderivater til fremstilling af lægemidler til behandling af sygdomme i de kognitive funktioner - Google Patents
Anvendelse af (omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)-1H-azolderivater til fremstilling af lægemidler til behandling af sygdomme i de kognitive funktionerInfo
- Publication number
- DK0497658T3 DK0497658T3 DK92400163.9T DK92400163T DK0497658T3 DK 0497658 T3 DK0497658 T3 DK 0497658T3 DK 92400163 T DK92400163 T DK 92400163T DK 0497658 T3 DK0497658 T3 DK 0497658T3
- Authority
- DK
- Denmark
- Prior art keywords
- radical
- alkyl
- manufacture
- treatment
- aryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9100861A FR2671972B1 (fr) | 1991-01-25 | 1991-01-25 | Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0497658T3 true DK0497658T3 (da) | 1995-10-02 |
Family
ID=9409058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92400163.9T DK0497658T3 (da) | 1991-01-25 | 1992-01-22 | Anvendelse af (omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)-1H-azolderivater til fremstilling af lægemidler til behandling af sygdomme i de kognitive funktioner |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5182281A (de) |
| EP (1) | EP0497658B1 (de) |
| JP (1) | JPH07121865B2 (de) |
| KR (1) | KR970001655B1 (de) |
| AT (1) | ATE126227T1 (de) |
| AU (1) | AU646137B2 (de) |
| CA (1) | CA2059984A1 (de) |
| DE (1) | DE69203874T2 (de) |
| DK (1) | DK0497658T3 (de) |
| ES (1) | ES2125207B1 (de) |
| FR (1) | FR2671972B1 (de) |
| GR (1) | GR3017648T3 (de) |
| HU (1) | HU214319B (de) |
| NO (1) | NO179695C (de) |
| RU (1) | RU2078568C1 (de) |
| ZA (1) | ZA92504B (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681956A (en) * | 1990-12-28 | 1997-10-28 | Neurogen Corporation | 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| US5646281A (en) * | 1990-12-28 | 1997-07-08 | Neurogen Corporation | Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands |
| FR2701260B1 (fr) * | 1993-02-05 | 1995-05-05 | Esteve Labor Dr | Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments. |
| FR2705098B1 (fr) * | 1993-05-10 | 1995-08-04 | Esteve Labor Dr | Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) . |
| GB9408084D0 (en) * | 1994-04-23 | 1994-06-15 | Boots Co Plc | Medical treatment |
| FR2723091B1 (fr) * | 1994-07-29 | 1996-11-08 | Esteve Labor Dr | Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles |
| US6355659B1 (en) | 1994-07-29 | 2002-03-12 | Laboratorios Del Dr. Esteve, S.A. | 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same |
| ES2117934B1 (es) * | 1994-07-29 | 1999-04-01 | Esteve Labor Dr | Tetrahidropiridinas (0 4-hidroxipiperidinas) alquilazoles. |
| ES2099031B1 (es) * | 1995-05-31 | 1997-12-01 | Esteve Labor Dr | Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen. |
| US6166205A (en) * | 1998-09-02 | 2000-12-26 | Neurogen Corporation | 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands |
| US9161783B2 (en) | 2004-10-20 | 2015-10-20 | Vertiflex, Inc. | Interspinous spacer |
| US8123807B2 (en) | 2004-10-20 | 2012-02-28 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
| US8273108B2 (en) | 2004-10-20 | 2012-09-25 | Vertiflex, Inc. | Interspinous spacer |
| US8945183B2 (en) * | 2004-10-20 | 2015-02-03 | Vertiflex, Inc. | Interspinous process spacer instrument system with deployment indicator |
| US8167944B2 (en) | 2004-10-20 | 2012-05-01 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
| US9023084B2 (en) * | 2004-10-20 | 2015-05-05 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for stabilizing the motion or adjusting the position of the spine |
| US8277488B2 (en) * | 2004-10-20 | 2012-10-02 | Vertiflex, Inc. | Interspinous spacer |
| US8128662B2 (en) | 2004-10-20 | 2012-03-06 | Vertiflex, Inc. | Minimally invasive tooling for delivery of interspinous spacer |
| US7763074B2 (en) | 2004-10-20 | 2010-07-27 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
| US8123782B2 (en) * | 2004-10-20 | 2012-02-28 | Vertiflex, Inc. | Interspinous spacer |
| US8409282B2 (en) | 2004-10-20 | 2013-04-02 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
| US8012207B2 (en) * | 2004-10-20 | 2011-09-06 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
| US9119680B2 (en) | 2004-10-20 | 2015-09-01 | Vertiflex, Inc. | Interspinous spacer |
| US8613747B2 (en) * | 2004-10-20 | 2013-12-24 | Vertiflex, Inc. | Spacer insertion instrument |
| US8152837B2 (en) | 2004-10-20 | 2012-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
| US8317864B2 (en) | 2004-10-20 | 2012-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
| US8425559B2 (en) | 2004-10-20 | 2013-04-23 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
| WO2009086010A2 (en) | 2004-12-06 | 2009-07-09 | Vertiflex, Inc. | Spacer insertion instrument |
| US8845726B2 (en) | 2006-10-18 | 2014-09-30 | Vertiflex, Inc. | Dilator |
| WO2008130564A1 (en) | 2007-04-16 | 2008-10-30 | Vertiflex Inc. | Interspinous spacer |
| AU2009206098B2 (en) * | 2008-01-15 | 2014-10-30 | Vertiflex, Inc. | Interspinous spacer |
| WO2011084477A2 (en) | 2009-12-15 | 2011-07-14 | Vertifex, Inc. | Spinal spacer for cervical and other vertebra, and associated systems and methods |
| US9675303B2 (en) | 2013-03-15 | 2017-06-13 | Vertiflex, Inc. | Visualization systems, instruments and methods of using the same in spinal decompression procedures |
| US10524772B2 (en) | 2014-05-07 | 2020-01-07 | Vertiflex, Inc. | Spinal nerve decompression systems, dilation systems, and methods of using the same |
| US12102542B2 (en) | 2022-02-15 | 2024-10-01 | Boston Scientific Neuromodulation Corporation | Interspinous spacer and methods and systems utilizing the interspinous spacer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2642759B1 (fr) * | 1989-02-09 | 1991-05-17 | Laboratorios Esteve Sa | Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante |
| FR2654621B1 (fr) * | 1989-11-22 | 1994-09-23 | Esteve Labor Dr | Inhibition du syndrome d'abstinence. |
-
1991
- 1991-01-25 FR FR9100861A patent/FR2671972B1/fr not_active Expired - Lifetime
-
1992
- 1992-01-17 ES ES9200092A patent/ES2125207B1/es not_active Expired - Fee Related
- 1992-01-22 DK DK92400163.9T patent/DK0497658T3/da active
- 1992-01-22 DE DE69203874T patent/DE69203874T2/de not_active Expired - Fee Related
- 1992-01-22 AT AT92400163T patent/ATE126227T1/de not_active IP Right Cessation
- 1992-01-22 EP EP92400163A patent/EP0497658B1/de not_active Expired - Lifetime
- 1992-01-23 AU AU10445/92A patent/AU646137B2/en not_active Ceased
- 1992-01-24 NO NO920342A patent/NO179695C/no not_active IP Right Cessation
- 1992-01-24 JP JP4011131A patent/JPH07121865B2/ja not_active Expired - Lifetime
- 1992-01-24 CA CA002059984A patent/CA2059984A1/fr not_active Abandoned
- 1992-01-24 HU HU9200232A patent/HU214319B/hu not_active IP Right Cessation
- 1992-01-24 ZA ZA92504A patent/ZA92504B/xx unknown
- 1992-01-24 KR KR1019920001052A patent/KR970001655B1/ko not_active IP Right Cessation
- 1992-01-24 RU SU925010696A patent/RU2078568C1/ru active
- 1992-01-24 US US07/824,995 patent/US5182281A/en not_active Expired - Fee Related
-
1995
- 1995-10-04 GR GR950402761T patent/GR3017648T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO920342D0 (no) | 1992-01-24 |
| NO920342L (no) | 1992-07-27 |
| CA2059984A1 (fr) | 1992-07-26 |
| ATE126227T1 (de) | 1995-08-15 |
| DE69203874T2 (de) | 1995-12-07 |
| US5182281A (en) | 1993-01-26 |
| RU2078568C1 (ru) | 1997-05-10 |
| KR970001655B1 (ko) | 1997-02-13 |
| JPH04312529A (ja) | 1992-11-04 |
| AU1044592A (en) | 1992-07-30 |
| KR920014472A (ko) | 1992-08-25 |
| ZA92504B (en) | 1992-10-28 |
| EP0497658B1 (de) | 1995-08-09 |
| GR3017648T3 (en) | 1996-01-31 |
| EP0497658A1 (de) | 1992-08-05 |
| ES2125207B1 (es) | 1999-01-01 |
| DE69203874D1 (de) | 1995-09-14 |
| HU214319B (hu) | 1998-03-02 |
| HU9200232D0 (en) | 1992-04-28 |
| NO179695B (no) | 1996-08-26 |
| AU646137B2 (en) | 1994-02-10 |
| FR2671972A1 (fr) | 1992-07-31 |
| NO179695C (no) | 1996-12-04 |
| HUT60433A (en) | 1992-09-28 |
| FR2671972B1 (fr) | 1995-03-03 |
| JPH07121865B2 (ja) | 1995-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0497658T3 (da) | Anvendelse af (omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)-1H-azolderivater til fremstilling af lægemidler til behandling af sygdomme i de kognitive funktioner | |
| NO304071B1 (no) | Heterocyklisk-cykliske amin-derivater | |
| CY1107108T1 (el) | Παραγωγα αρυλομεθυλο-καρβονυλαμινο-θειαζολης και χρησις των ως αντινεοπλασματικοι παραγοντες | |
| DE69316067D1 (de) | Arzneimittel zur Verwendung bei der Behandlung von Parkinsonismus | |
| ATE170530T1 (de) | Thiazolidinderivate, ihre herstellung und medikamente, die sie enthalten | |
| NO304980B1 (no) | Substituerte 3-(aminoalkylamino)-1,2-benzisoksazoler og beslektede forbindelser, farmas°ytiske preparater inneholdende dem og deres anvendelse for fremstilling av legemidler | |
| DK0649418T3 (da) | 7-(2-aminoethyl)benzothiazolon | |
| BR9812239A (pt) | Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto | |
| ATE73785T1 (de) | 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amin - 6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung. | |
| DK64191A (da) | 4-methyl-5-(2-(4-phenyl-1-piperazinyl)ethyl)thiazolderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende thiazolderivaterne | |
| GR890300055T1 (en) | Aromatic derivatives of butyric acid, process for their preparation and their cosmetic and pharmaceutical use | |
| ATE92058T1 (de) | Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alphaaryl-(alpha-alkyl)-methoxy)-butyl)-1-piperaziny > mit serotoninergischer wirkung. | |
| AU2796695A (en) | Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders | |
| RU93004471A (ru) | Пиперидилокси- и хинуклидинилокси-изоксазоловые производные и фармацевтическая композиция на их основе |